BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28039524)

  • 1. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
    Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
    Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
    Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterases: relating structure and function.
    Francis SH; Turko IV; Corbin JD
    Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterases in cultured normal and RCS rat pigment epithelium: kinetics of cyclic AMP and cyclic GMP hydrolysis.
    Kurtz MJ; Edwards RB; Schmidt SY
    Exp Eye Res; 1987 Jul; 45(1):67-75. PubMed ID: 2820772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
    Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
    Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases in pancreatic islets.
    Pyne NJ; Furman BL
    Diabetologia; 2003 Sep; 46(9):1179-89. PubMed ID: 12904862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase.
    He Q; Wang F; Liu S; Zhu D; Cong H; Gao F; Li B; Wang H; Lin Z; Liao J; Gu L
    J Biol Chem; 2016 Feb; 291(7):3668-81. PubMed ID: 26668313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.